SPOILER ALERT!
Health Issues Connected to Zantac®
Due to results from laboratory testing, the US FDA has determined that Zantac® and various ranitidine based medicines contain a nitrosamine issue named N–nitrosodimethylamine (NDMA) at lower levels. NDMA is thought of as a probable human carcinogen – a substance may cause cancer in humans. NDMA is a classified environmental contaminant and noticed in water and foods, including meat, dairy items, and vegetables.
What is NDMA?
N–nitrosodimethylamine (NDMA) is known as a likely human carcinogen which means that it’s more probable than not to cause cancer in humans. NDMA has been researched in animal populations and found to increase the occurrence of cancer in the animals. The studies have enhanced the opportunity of an connection between NDMA and liver toxicity which might lead to the development of liver cancer and other connected conditions brought about from an NDMA–induced treatment of the liver.
The degree and length of human NDMA exposure that can begin the development of cancer is not precisely known. Also, the extent and length of the NDMA contamination of Zantac® and other ranitidine medicines are not exactly known.
Diseases Associated with Exposure to NDMA
NDMA has been studied in animal populations and observed to increase the happening of cancer in the animals. Based on these studies, the Environmental Protection Agency classifies NDMA as a likely human carcinogen. The research has raised the likeliness of a connection between NDMA and liver toxicity that can lead to the development of liver cancer and other associated conditions created by an NDMA injury to the liver. Others have stated that NDMA could also be linked to other cancers such as:
Bladder Cancer, Liver Cancer, Prostate Cancer, Leukemia.
Have Other Ranitidine Products Been Recalled?
Yes. The U.S. Food and Drug Administration has alerted health care professionals and patients to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets because of the potential of N–Nitrosodimethylamine (NDMA) in the medicine.
Novitium Pharma LLC has voluntarily recalled all unexpired quantities and lots of ranitidine hydrochloride medication due to the possibility of NDMA in the medicine.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.
Should zantac Stop Taking Zantac® or Other Ranitidine Medications?
As of October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medications as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. zantac of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Consultation
Meneo Law Group is a leading consumer advocate for the recovery of damages because of to NDMA injury. Feel free to contact us at any time to discuss your injury and potential for recovery.
What is NDMA?
N–nitrosodimethylamine (NDMA) is known as a likely human carcinogen which means that it’s more probable than not to cause cancer in humans. NDMA has been researched in animal populations and found to increase the occurrence of cancer in the animals. The studies have enhanced the opportunity of an connection between NDMA and liver toxicity which might lead to the development of liver cancer and other connected conditions brought about from an NDMA–induced treatment of the liver.
The degree and length of human NDMA exposure that can begin the development of cancer is not precisely known. Also, the extent and length of the NDMA contamination of Zantac® and other ranitidine medicines are not exactly known.
Diseases Associated with Exposure to NDMA
NDMA has been studied in animal populations and observed to increase the happening of cancer in the animals. Based on these studies, the Environmental Protection Agency classifies NDMA as a likely human carcinogen. The research has raised the likeliness of a connection between NDMA and liver toxicity that can lead to the development of liver cancer and other associated conditions created by an NDMA injury to the liver. Others have stated that NDMA could also be linked to other cancers such as:
Bladder Cancer, Liver Cancer, Prostate Cancer, Leukemia.
Have Other Ranitidine Products Been Recalled?
Yes. The U.S. Food and Drug Administration has alerted health care professionals and patients to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets because of the potential of N–Nitrosodimethylamine (NDMA) in the medicine.
Novitium Pharma LLC has voluntarily recalled all unexpired quantities and lots of ranitidine hydrochloride medication due to the possibility of NDMA in the medicine.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.
Should zantac Stop Taking Zantac® or Other Ranitidine Medications?
As of October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medications as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. zantac of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Consultation
Meneo Law Group is a leading consumer advocate for the recovery of damages because of to NDMA injury. Feel free to contact us at any time to discuss your injury and potential for recovery.
SPOILER ALERT!
Bad Injuries Connected to Zantac®
Based on results from Lab testing, the US FDA has learned that Zantac® and other ranitidine based medications contain a nitrosamine impurity named N–nitrosodimethylamine (NDMA) at lower levels. NDMA is classified as a probable human carcinogen – a substance may cause cancer in humans. NDMA is a known environmental contaminant and observed in water supplies and food sources, including meat, dairy products, and vegetables.
What is NDMA?
N–nitrosodimethylamine (NDMA) is classified as a probable human carcinogen which means that it’s more likely than not to cause cancer in humans. zantac has been studied in animal populations and found to increase the creation of cancer in the animals. The research has enhanced the opportunity of an association between NDMA and liver toxicity that might lead to the development of liver cancer and various connected conditions created from an NDMA–induced reaction to the liver.
The degree and duration of human NDMA exposure which can lead to the development of cancer is not precisely known. Similarly, the extent and length of the NDMA contamination of Zantac® and other ranitidine medicines are not exactly understood.
Issues Connected with Exposure to NDMA
NDMA has been researched in animal groups and determined to increase the creation of cancer in the animals. Based on these studies, the U.S. Environmental Protection Agency classifies NDMA as a probable human carcinogen. The studies have increased the probability of a connection between NDMA and liver toxicity that can lead to the creation of liver cancer and various related issues created by an NDMA injury to the liver. Some have claimed that NDMA may also be associated to other cancers such as:
Small Intestine Cancer, Liver Cancer, Pancreatic Cancer, Leukemia.
Has Other Ranitidine Products Been Recalled?
Yes. The U.S. Food and Drug Administration has contacted health care professionals and patients to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets due to the potential of N–Nitrosodimethylamine (NDMA) in the medicine.
Novitium Pharma LLC has voluntarily recalled all unexpired amounts and lots of ranitidine hydrochloride capsules due to the possibility of NDMA in the medication.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.
Should I Cease Taking Zantac® or Other Ranitidine Medicines?
On October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medications as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. zantac taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Consultation
Meneo Law Group is a leading consumer law firm for the recovery of damages because of to NDMA exposure. Feel free to contact us at any time to discuss your injury and potential for recovery.
What is NDMA?
N–nitrosodimethylamine (NDMA) is classified as a probable human carcinogen which means that it’s more likely than not to cause cancer in humans. zantac has been studied in animal populations and found to increase the creation of cancer in the animals. The research has enhanced the opportunity of an association between NDMA and liver toxicity that might lead to the development of liver cancer and various connected conditions created from an NDMA–induced reaction to the liver.
The degree and duration of human NDMA exposure which can lead to the development of cancer is not precisely known. Similarly, the extent and length of the NDMA contamination of Zantac® and other ranitidine medicines are not exactly understood.
Issues Connected with Exposure to NDMA
NDMA has been researched in animal groups and determined to increase the creation of cancer in the animals. Based on these studies, the U.S. Environmental Protection Agency classifies NDMA as a probable human carcinogen. The studies have increased the probability of a connection between NDMA and liver toxicity that can lead to the creation of liver cancer and various related issues created by an NDMA injury to the liver. Some have claimed that NDMA may also be associated to other cancers such as:
Small Intestine Cancer, Liver Cancer, Pancreatic Cancer, Leukemia.
Has Other Ranitidine Products Been Recalled?
Yes. The U.S. Food and Drug Administration has contacted health care professionals and patients to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets due to the potential of N–Nitrosodimethylamine (NDMA) in the medicine.
Novitium Pharma LLC has voluntarily recalled all unexpired amounts and lots of ranitidine hydrochloride capsules due to the possibility of NDMA in the medication.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.
Should I Cease Taking Zantac® or Other Ranitidine Medicines?
On October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medications as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. zantac taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Consultation
Meneo Law Group is a leading consumer law firm for the recovery of damages because of to NDMA exposure. Feel free to contact us at any time to discuss your injury and potential for recovery.
Health Issues Linked to Zantac®
Due to results from Lab evaluation, the U.S. FDA has learned that Zantac® and other ranitidine based medications contain a nitrosamine issue called N–nitrosodimethylamine (NDMA) at low amounts. NDMA is classified as a likely human carcinogen – a substance may cause cancer in humans. NDMA is a classified environmental contaminant and found in water supplies and food sources, including meat, dairy products, and vegetables.
What is NDMA?
N–nitrosodimethylamine (NDMA) is classified as a likely human carcinogen which means that it is more probable than not to cause cancer in humans. NDMA has been studied in animal populations and observed to increase the occurrence of cancer in the animals. The studies have raised the opportunity of an connection between NDMA and liver toxicity that might lead to the development of liver cancer and other connected conditions created by an NDMA–induced treatment of the liver.
The degree and length of human NDMA exposure which can begin the development of cancer is not precisely known. Also, the amount and duration of the NDMA contamination of Zantac® and other ranitidine medicines are not precisely understood.
Issues Connected with Exposure to NDMA
NDMA has been studied in animal populations and observed to increase the happening of cancer in the animals. In light of these studies, the US EPA classifies NDMA as a likely human carcinogen. The research has increased the probability of a connection between NDMA and liver toxicity which may lead to the development of liver cancer and other related conditions created by an NDMA injury to the liver. Some have stated that NDMA could also be associated to other cancers such as:
Bladder Cancer, Colorectal Cancer, Prostate Cancer, Leukemia.
Have Other Ranitidine Products Been Recalled?
Yes. The U.S. Food and Drug Administration has informed health care professionals and patients to three existing voluntary recalls of ranitidine.
zanac attorney has voluntarily recalled over–the–counter (OTC) ranitidine tablets due to the possibility of N–Nitrosodimethylamine (NDMA) in the medication.
Novitium Pharma LLC has voluntarily recalled all unexpired amounts and lots of ranitidine hydrochloride medication due to the possibility of NDMA in the medication.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup because of the presence of NDMA found in the drug.
Should I Cease Taking Zantac® or Other Ranitidine Medications?
As of October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medicines as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Consultation
Meneo Law Group is a leading consumer advocate for the recovery of damages due to NDMA exposure. Feel free to reach out at any time to explore your injury and potential for recovery.
What is NDMA?
N–nitrosodimethylamine (NDMA) is classified as a likely human carcinogen which means that it is more probable than not to cause cancer in humans. NDMA has been studied in animal populations and observed to increase the occurrence of cancer in the animals. The studies have raised the opportunity of an connection between NDMA and liver toxicity that might lead to the development of liver cancer and other connected conditions created by an NDMA–induced treatment of the liver.
The degree and length of human NDMA exposure which can begin the development of cancer is not precisely known. Also, the amount and duration of the NDMA contamination of Zantac® and other ranitidine medicines are not precisely understood.
Issues Connected with Exposure to NDMA
NDMA has been studied in animal populations and observed to increase the happening of cancer in the animals. In light of these studies, the US EPA classifies NDMA as a likely human carcinogen. The research has increased the probability of a connection between NDMA and liver toxicity which may lead to the development of liver cancer and other related conditions created by an NDMA injury to the liver. Some have stated that NDMA could also be associated to other cancers such as:
Bladder Cancer, Colorectal Cancer, Prostate Cancer, Leukemia.
Have Other Ranitidine Products Been Recalled?
Yes. The U.S. Food and Drug Administration has informed health care professionals and patients to three existing voluntary recalls of ranitidine.
zanac attorney has voluntarily recalled over–the–counter (OTC) ranitidine tablets due to the possibility of N–Nitrosodimethylamine (NDMA) in the medication.
Novitium Pharma LLC has voluntarily recalled all unexpired amounts and lots of ranitidine hydrochloride medication due to the possibility of NDMA in the medication.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup because of the presence of NDMA found in the drug.
Should I Cease Taking Zantac® or Other Ranitidine Medications?
As of October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medicines as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Consultation
Meneo Law Group is a leading consumer advocate for the recovery of damages due to NDMA exposure. Feel free to reach out at any time to explore your injury and potential for recovery.
